← Eichor
Condition: Macrophage Activation Syndrome Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Macrophage Activation Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07312474A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/
Phase 3 · 18 location(s) · TJ Biopharma Co., Ltd. · NCT07208058Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease
NA · 1 location(s) · Maria Cecilia Hospital · NCT07588295
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.